Akintomide GS, Rickards H (2011) Narcolepsy: a review. Neuropsychiatric Disease and Treatment 7: 507-518

Cvetkovic-Lopes V en 14 anderen (2010) Elevated Tribbels homolog 2-specific antibody levels in narcolepsy patients. The Journal of Clinical Investigation 120: 713-719

Dorris L, Zuberi SM, Scott N, Moffat C, McArthur I (2008) Psychosocial and intellectual functioning in childhood narcolepsy. Developmental Neurorehabilitation 11: 187-194

Fronczek R, van Geest S, Frölich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF (2011) Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiology Aging, Epub May 3á

Fronczek R, van der Zande WLM, van Dijk JG, Overeem S, Lammers GJ (2007) Narcolepsie : diagnostiek en behandeling in nieuw perspectief. Nederlands Tijdschrift voor Geneeskunde 151; 856-861

Hor H, Bartesaghi L, Kutalik Z, Vicário JL, de AndréThe s C, Pfister C, Lammers GJ, Guex N Chrast R , Tafti M, Peraita-Adrados R (2011) A missence mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. The American Journal of Human Genetics 89: 474 - 479

Kornum BR, Faraco J, Migriot E (2011) Narcolepsy with hyocretin/orexin deficiency, infections and autoimmunity of the brain. Current Opinion in Neurobiology 21: 1-7

Lammers GJ en 24 anderen (2010) Sodium oxybate is an effective and safe treatment for narcolepsy. Response from Zvosec DL, Smith SW, Hall BJ. Sleep Medicine 11: 105-109

Naumann A, Bellebaum C, Daum I (2006) Cognitive deficits in narcolepsy. Journal of Sleep Research 15: 329-338

Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ (2011) The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin1 deficiency. Sleep Medicine 12: 12-18

Stores G, Montgomery P, Wiggs L (2006) The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 118: e1116- 1123